Evidence map›Paper›PMID 34965702›Full record

ArticleHaematologica2022

Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination.

Giovanni Caocci, Daniela Fanni, Mariagrazia Porru, Marianna Greco, Sonia Nemolato, Davide Firinu, Gavino Faa, Angelo Scuteri, Giorgio La Nasa

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Kikuchi-Fujimoto disease: A comprehensive review.World journal of clinical cases · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Giovanni CaocciDepartment of Medical Sciences and Public Health, Haematology, University of Cagliari, Businco Hospital, Cagliari. giovanni.caocci@unica.it.
Daniela FanniDepartment of Medical Sciences and Public Health, Pathology, University of Cagliari, S.Giovanni di Dio and Businco Hospital, Cagliari.
Mariagrazia PorruDepartment of Medical Sciences and Public Health, Internal Medicine, University of Cagliari, Policlinico Hospital, Cagliari.
Marianna GrecoDepartment of Medical Sciences and Public Health, Haematology, University of Cagliari, Businco Hospital, Cagliari.
Sonia NemolatoDepartment of Medical Sciences and Public Health, Pathology, University of Cagliari, S.Giovanni di Dio and Businco Hospital, Cagliari.
Davide FirinuDepartment of Medical Sciences and Public Health, Internal Medicine, University of Cagliari, Policlinico Hospital, Cagliari.
Gavino FaaDepartment of Medical Sciences and Public Health, Pathology, University of Cagliari, S.Giovanni di Dio and Businco Hospital, Cagliari.
Angelo ScuteriDepartment of Medical Sciences and Public Health, Internal Medicine, University of Cagliari, Policlinico Hospital, Cagliari.
Giorgio La NasaDepartment of Medical Sciences and Public Health, Haematology, University of Cagliari, Businco Hospital, Cagliari.
University of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Histiocytic Necrotizing LymphadenitisLymphohistiocytosis, HemophagocyticBNT162 VaccineCOVID-19 VaccinesHumansRNA, MessengerVaccinationBNT162 VaccineCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID34965702
PMCPMC9052929
OpenAlexW4200555822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.